語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Extremophilic cyanobacteria for nove...
~
Rath, Jnanendra.
Extremophilic cyanobacteria for novel drug development
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Extremophilic cyanobacteria for novel drug development/ by Sikha Mandal, Jnanendra Rath.
作者:
Mandal, Sikha.
其他作者:
Rath, Jnanendra.
出版者:
Cham :Springer International Publishing : : 2015.,
面頁冊數:
vii, 92 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Cyanobacteria - Therapeutic use. -
電子資源:
http://dx.doi.org/10.1007/978-3-319-12009-6
ISBN:
9783319120096 (electronic bk.)
Extremophilic cyanobacteria for novel drug development
Mandal, Sikha.
Extremophilic cyanobacteria for novel drug development
[electronic resource] /by Sikha Mandal, Jnanendra Rath. - Cham :Springer International Publishing :2015. - vii, 92 p. :ill., digital ;24 cm. - SpringerBriefs in pharmaceutical science & drug development,1864-8118. - SpringerBriefs in pharmaceutical science & drug development..
1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
ISBN: 9783319120096 (electronic bk.)
Standard No.: 10.1007/978-3-319-12009-6doiSubjects--Topical Terms:
1064676
Cyanobacteria
--Therapeutic use.
LC Class. No.: QR46.5 / .M36 2015
Dewey Class. No.: 615.32939
Extremophilic cyanobacteria for novel drug development
LDR
:02566nam a2200325 a 4500
001
835407
003
DE-He213
005
20150724132457.0
006
m d
007
cr nn 008maaau
008
160421s2015 gw s 0 eng d
020
$a
9783319120096 (electronic bk.)
020
$a
9783319120089 (paper)
024
7
$a
10.1007/978-3-319-12009-6
$2
doi
035
$a
978-3-319-12009-6
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QR46.5
$b
.M36 2015
072
7
$a
TDCW
$2
bicssc
072
7
$a
MED072000
$2
bisacsh
082
0 4
$a
615.32939
$2
23
090
$a
QR46.5
$b
.M271 2015
100
1
$a
Mandal, Sikha.
$3
1064674
245
1 0
$a
Extremophilic cyanobacteria for novel drug development
$h
[electronic resource] /
$c
by Sikha Mandal, Jnanendra Rath.
260
$a
Cham :
$c
2015.
$b
Springer International Publishing :
$b
Imprint: Springer,
300
$a
vii, 92 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
SpringerBriefs in pharmaceutical science & drug development,
$x
1864-8118
505
0
$a
1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
520
$a
This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
650
0
$a
Cyanobacteria
$x
Therapeutic use.
$3
1064676
650
0
$a
Drug development.
$3
581824
650
0
$a
Pharmaceutical microbiology.
$3
1060343
650
0
$a
Extreme environments
$x
Microbiology.
$3
668820
650
0
$a
Microbial metabolites.
$3
1064677
650
1 4
$a
Biomedicine.
$3
593880
650
2 4
$a
Pharmaceutical Sciences/Technology.
$3
768561
700
1
$a
Rath, Jnanendra.
$3
1064675
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
SpringerBriefs in pharmaceutical science & drug development.
$3
885020
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-12009-6
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入